Literature DB >> 2990147

Characterization of four human malignant glioma cell lines.

A Studer, N de Tribolet, A C Diserens, A C Gaide, J M Matthieu, S Carrel, D Stavrou.   

Abstract

In this paper, the characterization of four human malignant glioma cell lines is described. The four lines are positive for glial fibrillary acidic protein (GFAP) in variable amounts. One of them, LN 992, is positive for S-100 protein. Myelin basic protein could not be detected in any of the four lines. The four lines had high levels of CNPase activity. The karyotype shows polyploidy for all lines, with modal numbers ranging from 80 to 120 and various numbers of marker chromosomes. Particular attention has been paid to the surface phenotype and a panel of three antiglioma monoclonal antibodies (Mabs), five antimelanoma Mabs, one anti-CALLA Mab, and two anti-HLA-DR Mabs has been used in an antibody-binding radioimmunoassay for the four cell lines. Lines LN 215 and LN 235 are positive with two antiglioma Mabs, LN 992 is negative. The four lines are positive with all five antimelanoma Mabs, except for LN 992 which ist negative with Mab D5. LN 992 and LN 215 are positive with the anti-CALLA Mab N2A12. LN 308 and LN 992 are positive with anti-HLA-DR Mab D4-22. There was no correlation between the in vitro morphology of the lines and the expression of the various biochemical or surface markers. These results stress the heterogeneity of the phenotype of human malignant glioma lines. These lines will be useful tools for further immunologic studies.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2990147     DOI: 10.1007/bf00688585

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  29 in total

1.  Long term culture of normal and neoplastic human glia.

Authors:  J Pontén; E H Macintyre
Journal:  Acta Pathol Microbiol Scand       Date:  1968

2.  The regional and subcellular distribution of 2',3'-cyclic nucleotide 3'-phosphohydrolase in the central nervous system.

Authors:  T Kurihara; Y Tsukada
Journal:  J Neurochem       Date:  1967-12       Impact factor: 5.372

3.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

4.  Common human melanoma-associated antigen(s) detected by monoclonal antibodies.

Authors:  S Carrel; R S Accolla; A L Carmagnola; J P Mach
Journal:  Cancer Res       Date:  1980-07       Impact factor: 12.701

5.  Subsets of human Ia-like molecules defined by monoclonal antibodies.

Authors:  S Carrel; R Tosi; N Gross; N Tanigaki; A L Carmagnola; R S Accolla
Journal:  Mol Immunol       Date:  1981-05       Impact factor: 4.407

6.  A simple cytochemical technique for demonstration of DNA in cells infected with mycoplasmas and viruses.

Authors:  W C Russell; C Newman; D H Williamson
Journal:  Nature       Date:  1975-02-06       Impact factor: 49.962

7.  Expression of HLA-DR and common acute lymphoblastic leukemia antigens on glioma cells.

Authors:  S Carrel; N De Tribolet; N Gross
Journal:  Eur J Immunol       Date:  1982-04       Impact factor: 5.532

8.  Selected morphological immunocytochemical and growth characteristics of three experimental rat gliomas and of their cells in vitro.

Authors:  D Stavrou; U Osterkamp; B Schröder; A P Anzil; K Zänker
Journal:  Exp Cell Biol       Date:  1979

9.  Reactivity of antiglioma monoclonal antibodies for a large panel of cultured gliomas and other neuroectoderm derived tumors.

Authors:  B de Muralt; N de Tribolet; A C Diserens; S Carrel; J P Mach
Journal:  Anticancer Res       Date:  1983 Jan-Feb       Impact factor: 2.480

10.  Characterization of an established human malignant glioma cell line: LN-18.

Authors:  A C Diserens; N de Tribolet; A Martin-Achard; A C Gaide; J F Schnegg; S Carrel
Journal:  Acta Neuropathol       Date:  1981       Impact factor: 17.088

View more
  13 in total

1.  Establishment and characterization of five cell lines derived from human malignant gliomas.

Authors:  J T Rutka; J R Giblin; D Y Dougherty; H C Liu; J R McCulloch; C W Bell; R S Stern; C B Wilson; M L Rosenblum
Journal:  Acta Neuropathol       Date:  1987       Impact factor: 17.088

2.  Changes in glial fibrillary acidic protein and karyotype during culturing of two cell lines established from human glioblastoma multiforme.

Authors:  V Bocchini; R Casalone; P Collini; G Rebel; F Lo Curto
Journal:  Cell Tissue Res       Date:  1991-07       Impact factor: 5.249

Review 3.  The immunobiology of human gliomas.

Authors:  V Piguet; A C Diserens; S Carrel; J P Mach; N de Tribolet
Journal:  Springer Semin Immunopathol       Date:  1985

4.  Establishment of two glioma cell lines from two surgical specimens obtained at different times from the same individual.

Authors:  K Onda; S Nagai; R Tanaka; K Morii; J I Yoshimura; I Tsumanuma; T Kumanishi
Journal:  J Neurooncol       Date:  1999-02       Impact factor: 4.130

5.  Improved technique for establishing short term human brain tumor cultures.

Authors:  M A Farr-Jones; I F Parney; K C Petruk
Journal:  J Neurooncol       Date:  1999-05       Impact factor: 4.130

6.  Role of Kir4.1 channels in growth control of glia.

Authors:  Haruki Higashimori; Harald Sontheimer
Journal:  Glia       Date:  2007-12       Impact factor: 7.452

7.  Characterization of a continuous human glioma cell line DBTRG-05MG: growth kinetics, karyotype, receptor expression, and tumor suppressor gene analyses.

Authors:  C A Kruse; D H Mitchell; B K Kleinschmidt-DeMasters; W A Franklin; H G Morse; E B Spector; K O Lillehei
Journal:  In Vitro Cell Dev Biol       Date:  1992 Sep-Oct

8.  Molecular cloning and primary structure of human glial fibrillary acidic protein.

Authors:  S A Reeves; L J Helman; A Allison; M A Israel
Journal:  Proc Natl Acad Sci U S A       Date:  1989-07       Impact factor: 11.205

9.  Activation of human platelet-derived latent transforming growth factor-beta 1 by human glioblastoma cells. Comparison with proteolytic and glycosidic enzymes.

Authors:  D Huber; A Fontana; S Bodmer
Journal:  Biochem J       Date:  1991-07-01       Impact factor: 3.857

Review 10.  Glioblastoma--a moving target.

Authors:  Bengt Westermark
Journal:  Ups J Med Sci       Date:  2012-05       Impact factor: 2.384

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.